BCLI - BrainStorm Cell Therapeutics EPS beats by $0.07 April, 26 2021 07:02 AM Brainstorm Cell Therapeutics Inc. BrainStorm Cell Therapeutics (BCLI): Q1 GAAP EPS of -$0.19 beats by $0.07.Cash and equivalents, and short-term bank deposits of $40.0M.Press Release For further details see: BrainStorm Cell Therapeutics EPS beats by $0.07